ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1241

Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort

Stephanie Fevrier1, Olivia Hendrikx1, Ashley Danguecan1, Asha Jeyanathan1, Lawrence Ng1, Ibrahim Mohamed2, Paris Moaf1, Sondos Ayyash1, Chelsea DeCoste3, Deborah Levy1, Linda Hiraki1 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Brampton, ON, Canada, 3IWK Health Centre, Halifax, NS, Canada

Meeting: ACR Convergence 2023

Keywords: Cognitive dysfunction, mental health, Pediatric rheumatology, Stroke, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease in which 20% of cases are diagnosed in childhood. Adverse childhood experiences (ACEs) are traumatic events or experiences occurring in childhood. While adult SLE patients with a history of ACEs report higher levels of depression, ACEs’ more immediate impact on adolescents with childhood-onset SLE (cSLE) is unknown. Research posits that ACEs and cSLE can be detrimental to the rapidly developing adolescent brain as they are both associated with an increased risk of cognitive impairment and mood disorders. This study aims to: 1) determine the prevalence of ACEs and 2) examine the relationship between ACEs and cognitive performance and mood disorder symptoms in cSLE.

Methods: We conducted a retrospective cohort study of participants ages 10-18 years who met the ACR or SLICC classification criteria for SLE. We identified 18 types of ACEs according to the CDC-Kaiser and Philadelphia ACEs frameworks through electronic medical records and responses from the PTSD section of the Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS). Outcomes of interest were: i) executive function (EF, measured by the Delis-Kaplan Executive Function System (D-KEFS)), ii) depression (Beck Depression Inventory-II (BDI-II), Children’s Depression Inventory-II (CDI-II) and Center for Epidemiological Studies Depression Scale for Children (CES-DC)), and iii) anxiety (Screen for Childhood Anxiety and Related Emotional Disorders (SCARED)), each available for subsets of the cohort. We tabulated the prevalence, types, and timing of ACEs. Multivariable regression analyses examined the relationship between binary ACEs exposure and EF (D-KEFS scaled scores) and the presence of clinically elevated depression and anxiety symptoms; all models were adjusted for sex and age at cSLE diagnosis.

Results: The study involved 224 patients; 85% were female, and 83% identified as non-white, with a median age at diagnosis of 13.2 (IQR 4.4) years and a median disease duration of 2.7 (IQR 5.9) years. Forty-one percent (n=92) of the cohort had at least one documented ACE, of which 60% (n=37) had ≥2 ACEs; 55% of these ACEs occurred before cSLE diagnosis. Of all ACEs types, parental separation/divorce, bullying, and parental mental illness were the most frequent (Figure 1). Multivariable linear regression analysis (sample n=45) showed a significant association between ACEs exposure and worse EF performance on D-KEFS (β = -2.93, 95% CI [-5.04, -0.82], p = 0.008) (Figure 2). ACEs exposure was significantly associated with clinically elevated depression symptoms (OR = 4.00, 95% CI [1.63, 10.43], p = 0.003, sample n=97) (Figure 3). No association was found between ACEs exposure and clinically elevated anxiety symptoms (OR = 1.07, 95% CI [0.47, 2.46], p = 0.868, sample n=99).

Conclusion: ACEs negatively impact EF performance and mental health in children and adolescents with SLE. Further investigation is required into the neuropsychiatric consequences of ACEs and potential biological pathways that enable these deleterious outcomes in youth with cSLE and other chronic illnesses.

Supporting image 1

Figure 1. Bar chart showing the 18 ACEs types (adopted from the CDC-Kaiser and Philadelphia ACEs frameworks) and the frequency of each ACE among participants with documented ACEs. A total of n=172 ACEs events were identified among n=224 patients with cSLE.

Supporting image 2

Figure 2. Box plot showing findings from a multivariable linear regression model examining the associations between ACEs exposure and EF scores, adjusting for sex and age at cSLE. Scaled scores from the D-KEFS Colour-Word Interference Test (CWIT) were measured as a continuous variable (scores of ≤7 indicate below-average performance). EF data were available for a subset of 45 participants.

Supporting image 3

Figure 3. Odds plot showing findings from a multivariable logistic regression model examining the associations between ACEs exposure and the presence of clinically elevated depression symptoms, adjusting for sex and age at cSLE. Depression scores based on the BDI-II, CDI-II and CES-DC score classifications were measured as a binary variable and categorized as clinically elevated depression symptoms or not clinically elevated depression symptoms. Depression data were available for a subset of 97 participants.


Disclosures: S. Fevrier: None; O. Hendrikx: None; A. Danguecan: None; A. Jeyanathan: None; L. Ng: None; I. Mohamed: None; P. Moaf: None; S. Ayyash: None; C. DeCoste: None; D. Levy: None; L. Hiraki: None; A. Knight: Pfizer, 6.

To cite this abstract in AMA style:

Fevrier S, Hendrikx O, Danguecan A, Jeyanathan A, Ng L, Mohamed I, Moaf P, Ayyash S, DeCoste C, Levy D, Hiraki L, Knight A. Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/adverse-childhood-experiences-in-a-paediatric-systemic-lupus-erythematosus-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adverse-childhood-experiences-in-a-paediatric-systemic-lupus-erythematosus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology